about
Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling.Real-time histology in liver disease using multiphoton microscopy with fluorescence lifetime imaging.REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stemTwo-photon dual imaging platform for in vivo monitoring cellular oxidative stress in liver injury.Using the realist perspective to link theory from qualitative evidence synthesis to quantitative studies: Broadening the matrix approach.Split-dose bowel preparation with polyethylene glycol for colonoscopy performed under propofol sedation. Is there an optimal timing?Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.Studies of macrophage therapy for cirrhosis - From mice to men.Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study.A fat chance for hepatocyte transplantation?Long-Term Pioglitazone Treatment for Patients With Nonalcoholic SteatohepatitisOutcomes of a tertiary-based innovative approach to engage primary care providers in provision of hepatitis C treatment in community settings
P50
Q34563288-2F77163C-DFF5-4382-BB6D-EFEFDEB37C20Q34663415-1C902FE0-E3F9-4F33-B0D5-8DD206E7205CQ35181761-A76A0D3A-A613-40D0-A017-7C8325B1F669Q35203746-590E1A6A-35F4-4D57-9DBC-8FB9306D715AQ37724325-B3595023-2200-464F-95E5-633B760CDC54Q38827333-664DE8F2-D24A-4505-9F29-040A1EFF244CQ38868458-1E4E986C-F5EB-47C5-880A-3E8BBF7684F2Q46418008-F3AECC8F-8BFF-4C69-8906-79B383A7CE4FQ47109230-FE85D5C4-C116-4AD6-9602-3AFDFF6FA3E7Q50113895-D8BCBB2D-BBC1-44A7-B149-8277B75DE61FQ50524397-42D2B140-66AF-40AE-B999-F291C4F8E569Q50688665-B796D583-062D-4C08-9A64-CE43A8133B55Q62558143-56AC2253-5BE0-4E6F-B626-7ABCBBF943A3Q89213929-4130131A-732B-4A9C-A605-D2D563C25357Q90879842-86708145-7019-45E3-A052-6F066EAF2993
P50
description
researcher ORCID: 0000-0002-9122-950X
@en
name
James A Thomas
@ast
James A Thomas
@en
James A Thomas
@es
James A Thomas
@nl
James A Thomas
@sl
type
label
James A Thomas
@ast
James A Thomas
@en
James A Thomas
@es
James A Thomas
@nl
James A Thomas
@sl
altLabel
James Thomas
@en
prefLabel
James A Thomas
@ast
James A Thomas
@en
James A Thomas
@es
James A Thomas
@nl
James A Thomas
@sl
P1053
A-1272-2017
P106
P1153
55628531702
P21
P31
P496
0000-0002-9122-950X